Holland & Knight Health Dose is a weekly newsletter that provides stakeholders with an update on legislative and regulatory developments in Washington, D.C. that impact the health sector. This comprehensive update keeps readers informed on important issues shaping the healthcare landscape.
This week’s edition of Health Dose covers a range of topics, including Senator Cassidy’s questioning of FDA oversight of clinical decision support software and Buchanan’s call for MedPAC to reconsider their approach to digital health tools. Additionally, the conversation on surprise billing has been rekindled, with potential reforms being discussed in the areas of PBM, 340B, and Medicare PFS, as well as extensions for telehealth flexibility.
Other highlights in this week’s newsletter include retirements in the healthcare sector, a new center for clinical trial innovation announced by CDER, and updates from the CBO, CMS, FTC, and ONC.
For more information and the full Health Dose newsletter, please click on the link provided. Stay informed and up-to-date on the latest developments in health policy and regulation.
